|  Help  |  About  |  Contact Us

Publication : Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.

First Author  Brehm MA Year  2018
Journal  FASEB J Pages  fj201800636R
PubMed ID  30383447 Mgi Jnum  J:268035
Mgi Id  MGI:6271197 Doi  10.1096/fj.201800636R
Citation  Brehm MA, et al. (2018) Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB J :fj201800636R
abstractText  Immunodeficient mice engrafted with human peripheral blood mononuclear cells (PBMCs) support preclinical studies of human pathogens, allograft rejection, and human T-cell function. However, a major limitation of PBMC engraftment is development of acute xenogeneic graft- versus-host disease (GVHD) due to human T-cell recognition of murine major histocompatibility complex (MHC). To address this, we created 2 NOD- scid IL-2 receptor subunit gamma ( IL2rg) (null) (NSG) strains that lack murine MHC class I and II [NSG-beta-2-microglobulin ( B2M) (null) ( IA IE)(null) and NSG -( K(b) D(b)) (null) ( IA(null))]. We observed rapid human IgG clearance in NSG- B2M(null) ( IA IE) (null) mice whereas clearance in NSG -( K(b) D(b)) (null) ( IA(null)) mice and NSG mice was comparable. Injection of human PBMCs into both strains enabled long-term engraftment of human CD4(+) and CD8(+) T cells without acute GVHD. Engrafted human T-cell function was documented by rejection of human islet allografts. Administration of human IL-2 to NSG -( K(b) D(b)) (null) ( IA(null)) mice via adeno-associated virus vector increased human CD45(+) cell engraftment, including an increase in human regulatory T cells. However, high IL-2 levels also induced the development of GVHD. These data document that NSG mice deficient in murine MHC support studies of human immunity in the absence of acute GVHD and enable evaluation of human antibody therapeutics targeting human T cells.-Brehm, M. A., Kenney, L. L., Wiles, M. V., Low, B. E., Tisch, R. M., Burzenski, L., Mueller, C., Greiner, D. L., Shultz, L. D. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

21 Bio Entities

Trail: Publication

0 Expression